Cleared Traditional

K850231 - ALPHA MEM MEDIUM W/O NUCLEOSIDES (FDA 510(k) Clearance)

K850231 · Hazleton Research Products, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1985
Decision
42d
Days
-
Risk

K850231 is an FDA 510(k) clearance for the ALPHA MEM MEDIUM W/O NUCLEOSIDES.

Submitted by Hazleton Research Products, Inc. (Denver, US). The FDA issued a Cleared decision on March 5, 1985 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hazleton Research Products, Inc. devices

Submission Details

510(k) Number K850231 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 1985
Decision Date March 05, 1985
Days to Decision 42 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 77d · This submission: 42d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -